This evaluation is made in connection with my 5 years of omgoing ADT (Lupron) therapy.
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
That changes things significantly. Now I understand — this cardiac evaluation is part of your ongoing monitoring during ADT (androgen deprivation therapy) with Lupron, which is commonly used for prostate cancer.
This is very relevant to your cancer care, and I'm glad you're getting this monitoring.
Why Cardiac Monitoring During ADT?
ADT therapy (like Lupron) is known to affect cardiovascular health. According to ASCO (American Society of Clinical Oncology) guidelines, men on long-term ADT should have:
- Regular monitoring for metabolic changes
- Cardiovascular risk assessment
- Screening for heart disease, as ADT can increase cardiac risk factors
Your doctor ordered this coronary calcium scan as part of that important surveillance.
What I CAN Help With:
✅ Explain what terms in this report mean (calcified plaque, coronary calcium score, etc.)
✅ Describe why doctors monitor these findings during ADT
✅ Help you formulate questions for your oncologist about what this means for your ongoing treatment
What I CANNOT Do:
❌ Interpret what YOUR specific calcium score means for your heart health
❌ Recommend changes to your ADT therapy based on these findings
❌ Tell you whether you need cardiac intervention
Would you like me to:
- Explain specific medical terms from this report in plain language?
- Help you prepare questions to ask your oncologist about how these findings affect your ongoing ADT therapy?
- Provide general information about cardiovascular monitoring during long-term ADT?
Let me know which would be most helpful!
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2